After immunosuppressants, the best medicine for organ transplant patients may be gratitude.
In a study of organ recipients, researchers from UC Davis and the Mississippi University for Women found that patients who keep “gratitude journals” score better on measures of mental health, general health and vitality than those who keep only routine notes about their days.
“We found that increased feelings of gratitude can cause people’s well-being and quality of life to improve,” said Robert Emmons, a UC Davis professor who specializes in the study of gratitude.
Emmons conducted the study with Stefanie Greiner and Stephanie Ivie of the Mississippi University for Women. Titled “Gratitude and Quality of Life in Transplant Recipients,” the study will be presented as a poster at the annual meeting of the American Psychological Association.
The study included four male and 12 female transplant recipients recruited via transplant e-mail groups and Web sites for transplant recipients.
After completing initial questionnaires about their health and wellbeing, the subjects were randomly assigned to one of two groups. One group kept routine daily notes about medication side-effects, how they felt about life overall, how connected they were to others and how they felt about the upcoming day. Patients in the other group answered the same questions but were also asked to list five things or people they were grateful for each day and why they were grateful for them. They were asked to reflect on what they wrote as well.
After 21 days, mental health and general wellbeing scores had risen for patients in the gratitude group but declined for those in the control group. Patients in the control group also reported a loss of vitality, while the grateful patients experienced no change.
“It’s likely that health and vitality scores declined in the control group because, unlike the experimental group, they did not benefit from the protective effect of gratitude,” Emmons said. “Having a chronic medical condition puts one at risk for deteriorating mental health, and a reduction in one’s sense of general health and vitality is an indicator of this. Gratitude may serve as a buffer against these risks.”
Emmons is a leading contributor to the positive psychology movement and the author of the recently released book “Thanks! How the New Science of Gratitude Can Make You Happier.”
Source: University of California - Davis
Related stories:
The beat goes on: Artificial heart technology holds promise for alternatives
Patients on the waiting list for a heart transplant soon may have more options thanks to a new device being developed by the Texas Heart Institute in collaboration with two University of Houston professors.
Mayo researchers explore issues related to multiple myeloma treatment
Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Unfortunately, some of the most effective therapies also have toxic side effects that can pose serious health risks and reduce quality of life. In the October issue of
Mayo Clinic Proceedings, two articles authored by Mayo researchers address the issue of how to balance the risks and benefits associated with MM treatments.
Important new step toward producing stem cells for human treatment
(PhysOrg.com) -- A team of Harvard Stem Cell Institute (HSCI) scientists has taken an important step toward producing induced pluripotent stem (iPS) cells that are safe to transplant into patients to treat diseases.
New laboratory technique improves success in 'highly sensitized' kidney transplants
Kidney transplant specialists at Cedars-Sinai Medical Center have developed innovative laboratory techniques to improve opportunities and success rates for kidney transplant candidates who are at high risk of organ rejection because of previous exposure to donor antigens, according to an article in the Sept. 27 issue of the journal
Transplantation.
New gene variant identified for nondiabetic end stage renal disease in African-Americans
Scientists at Johns Hopkins schools of Public Health and Medicine have, for the first time, identified variants in the gene MYH9 that are associated with increased risk for non-diabetic end stage renal disease (ESRD,) which is the near-loss of kidney function leading to either dialysis of transplant. MYH9, located on the 22 chromosome, is the first gene identified for common forms of kidney disease. The study was published online September 14 in the journal
Nature Genetics and will be published in the October print edition. In a separate study published in the same issue, researchers at the National Institutes of Health reported similar findings.
New reasons to avoid grapefruit and other juices when taking certain drugs
Scientists and consumers have known for years that grapefruit juice can increase the absorption of certain drugs — with the potential for turning normal doses into toxic overdoses. Now, the researcher who first identified this interaction is reporting new evidence that grapefruit and other common fruit juices, including orange and apple, can do the opposite effect by substantially decreasing the absorption of other drugs, potentially wiping out their beneficial effects.
Researchers Combine Technologies to Heal Patients, Virtually
(PhysOrg.com) -- University of Arkansas researchers seeking new ways to make health care more efficient and cost-effective have built a new kind of hospital: one that uses location aware systems, sensors, smart devices, radio-frequency identification and virtual reality.
Liver damage in hepatitis C patients could be treated with warfarin, says study
The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.